Carillon Tower Advisers’s Enovis ENOV Stock Holding History

Carillon Tower Advisers’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,300	Closed	-$1.37M	–	480
2020 Q3	$1.37M	Buy	+25,300	New	+$1.39M	0.02%	429

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Carillon Tower Advisers's ENOV Position: Q4 2020 in Review

Carillon Tower Advisers sold out of Enovis (ENOV) in Q4 2020, closing a stake of 25,300 shares — an estimated $1.37M sold.

Carillon Tower Advisers first reported a position in ENOV in Q3 2020 and held it in 1 quarter. The position peaked at $1.37M in Q3 2020. 276 funds tracked by Wall St. Rank hold ENOV as of Q4 2020.

Carillon Tower Advisers reported no remaining Enovis position as of Q4 2020 after selling out during the quarter.
Carillon Tower Advisers sold 25,300 Enovis shares in Q4 2020, an estimated $1.37M.
Carillon Tower Advisers first reported a position in Enovis in Q3 2020 and held it in 1 quarter.
Carillon Tower Advisers's Enovis position peaked at $1.37M in Q3 2020.
276 funds tracked by Wall St. Rank held Enovis as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.